Dr. Robert S. Greenwood, MD

Expert Publications

• Adverse effects of antiepileptic drugs.
• Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides.
• Successful treatment of hypothalamic seizures and precocious puberty with GnRH analogue.
• Morphometric and neuropsychologic studies in children with arachnoid cysts.
• Did a rising tide lift all boats? The NIH budget and pediatric research portfolio.
• Ultrastructural distribution of glutamate immunoreactivity within neurosecretory endings and pituicytes of the rat neurohypophysis.
• Vasopressin mRNA expression in individual magnocellular neuroendocrine cells of the supraoptic and paraventricular nucleus in response to water deprivation.
• Methsuximide for intractable childhood seizures.
• Changing child neurology training: evolution or revolution?
• Diagnostic pitfalls associated with amoxapine overdose: a case report.
• Rapid loading of critically ill patients with carbamazepine suspension.
• Stroke-Like Presentation Following Febrile Seizure in a Patient with 1q43q44 Deletion Syndrome.
• Kindling in spontaneous hypertensive rats.

Media Releases

Get to know Pediatric Neurologist Dr. Robert S. Greenwood, who serves patients in Chapel Hill, North Carolina.

Dr. Greenwood is a triple board-certified pediatric neurologist whose special interests include child neurology, epilepsy, childhood headaches, neuroendocrinology, paroxysmal disorders, neurogenetics, neurocutaneous disorders, and Tourette’s syndrome. He works at UNC Hospitals Neurology Clinic & UNC Hospitals Children’s Specialty Clinic in Chapel Hill, North Carolina.

Alongside his clinical role, he serves as a Professor of Child Neurology within the Department of Neurology at UNC School of Medicine. 

The Child Neurology Division within the Department of Neurology offers specialized expertise in pediatric neurologic disorders. It provides comprehensive, high-quality neurological consultation and specialty neurological care to children with diseases affecting the nervous system and muscles. Diagnoses may include neurogenetic disorders, metabolic disorders, neurocutaneous disorders (e.g., neurofibromatosis, tuberous sclerosis, Sturge-Weber and others), childhood headaches, seizure disorders such as epilepsy, sleep disorders, neuromuscular diseases (e.g., muscular dystrophy and others) and cerebral palsy.

Graduating with his medical degree from the University of Texas Medical Branch at Galveston in 1968, Dr. Greenwood went on to further his training. He performed his residency in pediatrics/neurology at St. Louis Children’s Hospital in 1970, his residency in pediatrics at St. Louis Children’s Hospital in 1971, his fellowship in pediatrics/neurology at St. Louis Children’s Hospital in 1975, and his research fellowship in neurology at Barnes-Jewish Hospital in St. Louis in 1977.

Subsequent to his education, he attained board certification in neurology and child neurology through the American Board of Neurology and Psychiatry (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology. 

Furthermore, he attained board certification in pediatrics through the American Board of Pediatrics, whose mission is to advance child health by certifying pediatricians who meet standards of excellence and are committed to continuous learning and improvement.

Recognized as a skilled researcher, Dr. Greenwood’s interests in child neurology, childhood headaches, neuroendocrinology, neurofibromatosis and other neurocutaneous disorders, epilepsy and other paroxysmal disorders, mitochondrial disease, neurogenetics and Tourette’s syndrome, as well as the management of baclofen pumps.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. A child neurologist, or pediatric neurologist, is a doctor who treats children who have problems with their nervous system. Problems in the nervous system can start in the brain, spine, nerves, or muscles. These can lead to problems such as seizures, headaches, or developmental delays.

With over five decades of experience, Dr. Greenwood is the recipient of Compassionate Doctor Recognition (2014), Top 10 Doctor – State (2014), Patients’ Choice Award (2014, 2015, 2018), and On-Time Doctor Award (2018).

Recommended Articles

• Special Wish for 10 Year Old with Muscular Dystrophy

  Josh Banes is a young man from Louisiana with muscular dystrophy. At just 10 years old, a special dream came true for him right outside of the Bossier City, LA Police Department.Josh is fascinated by canine law enforcement. He loves canine officers and their dogs and read books about their...

• Family Raises $91K for Muscular Dystrophy

  The family of Chris and Jessica Curran from Lewisboro, a town in Westchester, New York, was filled with joy and love after 400 big hearted contributors flocked at the Brewing Company of Captain Lawrence in Elmsford, New York recently for a big benefit that helped raise $91K for Conner, their son,...

• Duchenne Muscular Dystrophy Therapy Receives Rare Pediatric Disease Designation

  Duchenne Muscular Dystrophy is characterized by progressive muscle degeneration paired with weakness.  This is caused by the lack of dystrophin.  This protein is the key to muscles staying strong and uninjured.  This disorder is typically found when a person is very young, as early as three years...

• What is World Autism Awareness Day?

  Just like everyone else, people with autism move through substantial life changes. Their quality of life depends on the foundation that was provided during their childhood. In addition, there is ongoing support revolving around their medical, educational, social and family needs. There is no single...

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...

• Chronic Inflammation May Enhance Sustained Delivery of New Muscular Dystrophy Therapy

  The Duchenne Muscular Dystrophy is a genetic disorder that is accompanied by symptoms of progressive muscle weakness and degeneration. Duchenne muscular dystrophy is caused by the absence of dystrophin, a protein that is responsible for keeping muscles cells intact, and accounts for one of the nine...